
### [MONDO:0017342](http://purl.obolibrary.org/obo/MONDO_0017342)
**Label:** Epstein-Barr virus-related tumor

**Subclasses:** [MONDO:0004952](http://purl.obolibrary.org/obo/MONDO_0004952) (Hodgkins lymphoma), [MONDO:0017343](http://purl.obolibrary.org/obo/MONDO_0017343) (Epstein-Barr virus-associated malignant lymphoproliferative disorder), [MONDO:0005058](http://purl.obolibrary.org/obo/MONDO_0005058) (leiomyosarcoma), [MONDO:0017345](http://purl.obolibrary.org/obo/MONDO_0017345) (Epstein-Barr virus-associated mesenchymal tumor), [MONDO:0017344](http://purl.obolibrary.org/obo/MONDO_0017344) (Epstein-Barr virus-associated carcinoma), [MONDO:0007243](http://purl.obolibrary.org/obo/MONDO_0007243) (Burkitts lymphoma), [MONDO:0013280](http://purl.obolibrary.org/obo/MONDO_0013280) (myxoid liposarcoma), [MONDO:0009348](http://purl.obolibrary.org/obo/MONDO_0009348) (classic Hodgkin lymphoma), [MONDO:0015459](http://purl.obolibrary.org/obo/MONDO_0015459) (nasopharynx carcinoma), 

**Corr. equiv. classes:** [Orphanet:64720](http://www.orpha.net/ORDO/Orphanet_64720), [Orphanet:150](http://www.orpha.net/ORDO/Orphanet_150), [Orphanet:98293](http://www.orpha.net/ORDO/Orphanet_98293), [OMIM:613488](http://purl.obolibrary.org/obo/OMIM_613488), [Orphanet:289656](http://www.orpha.net/ORDO/Orphanet_289656), [Orphanet:289644](http://www.orpha.net/ORDO/Orphanet_289644), [Orphanet:391](http://www.orpha.net/ORDO/Orphanet_391), [Orphanet:543](http://www.orpha.net/ORDO/Orphanet_543), [OMIM:113970](http://purl.obolibrary.org/obo/OMIM_113970), [Orphanet:289651](http://www.orpha.net/ORDO/Orphanet_289651), [OMIM:236000](http://purl.obolibrary.org/obo/OMIM_236000), 

**Class expressions from DL-Learner:**

- [HP:0002665](http://purl.obolibrary.org/obo/HP_0002665) (Lymphoma) and (not ([HP:0011121](http://purl.obolibrary.org/obo/HP_0011121) (Abnormality of skin morphology))) 49.80%
- [HP:0002665](http://purl.obolibrary.org/obo/HP_0002665) (Lymphoma) and (not ([HP:0000271](http://purl.obolibrary.org/obo/HP_0000271) (Abnormality of the face))) 48.33%
- [HP:0002665](http://purl.obolibrary.org/obo/HP_0002665) (Lymphoma) and (not ([HP:0000234](http://purl.obolibrary.org/obo/HP_0000234) (Abnormality of the head))) 48.33%
- [HP:0002665](http://purl.obolibrary.org/obo/HP_0002665) (Lymphoma) and (not ([HP:0000152](http://purl.obolibrary.org/obo/HP_0000152) (Abnormality of head or neck))) 48.33%
- [HP:0002665](http://purl.obolibrary.org/obo/HP_0002665) (Lymphoma) and (not ([HP:0010987](http://purl.obolibrary.org/obo/HP_0010987) (Abnormality of cellular immune system))) 44.25%
- [HP:0002665](http://purl.obolibrary.org/obo/HP_0002665) (Lymphoma) and (not ([HP:0001881](http://purl.obolibrary.org/obo/HP_0001881) (Abnormality of leukocytes))) 44.25%
- [HP:0002665](http://purl.obolibrary.org/obo/HP_0002665) (Lymphoma) and (not ([HP:0000163](http://purl.obolibrary.org/obo/HP_0000163) (Abnormality of the oral cavity))) 44.00%
- [HP:0002665](http://purl.obolibrary.org/obo/HP_0002665) (Lymphoma) and (not ([HP:0000153](http://purl.obolibrary.org/obo/HP_0000153) (Abnormality of the mouth))) 44.00%
- [HP:0002665](http://purl.obolibrary.org/obo/HP_0002665) (Lymphoma) and (not ([HP:0000164](http://purl.obolibrary.org/obo/HP_0000164) (Abnormality of the dentition))) 41.12%
- [HP:0002665](http://purl.obolibrary.org/obo/HP_0002665) (Lymphoma) and (not ([HP:0000498](http://purl.obolibrary.org/obo/HP_0000498) (Blepharitis))) 40.54%
- [HP:0002665](http://purl.obolibrary.org/obo/HP_0002665) (Lymphoma) and (not ([HP:0000389](http://purl.obolibrary.org/obo/HP_0000389) (Chronic otitis media))) 40.00%
- [HP:0002665](http://purl.obolibrary.org/obo/HP_0002665) (Lymphoma) 38.59%
- [HP:0001939](http://purl.obolibrary.org/obo/HP_0001939) (Abnormality of metabolism/homeostasis) and [HP:0002665](http://purl.obolibrary.org/obo/HP_0002665) (Lymphoma) 36.00%
- [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) 35.16%
- [HP:0002664](http://purl.obolibrary.org/obo/HP_0002664) (Neoplasm) 34.77%


